The price of Seer Inc. (NASDAQ:SEER) shares last traded on Wall Street rose 5.02% to $8.58.
SEER stock price is now 9.29% away from the 50-day moving average and -16.20% away from the 200-day moving average. The market capitalization of the company currently stands at $511.80M.
With the price target reduced from $20 to $12, JP Morgan Downgraded its rating from Overweight to Neutral for Seer Inc. (NASDAQ: SEER)., while ‘Morgan Stanley’ rates the stock as ‘Equal-Weight’.
In other news, Kogan Elona Esq., General Counsel and Secretary sold 8,185 shares of the company’s stock on Jun 08. The stock was sold for $72,923 at an average price of $8.91. Upon completion of the transaction, the General Counsel and Secretary now directly owns 101,370 shares in the company, valued at $0.87 million. An SEC document containing details of the transaction can be found on the SEC’s website. On May 27, President & COO OSTADAN OMEAD sold 4,441 shares of the business’s stock. A total of $35,794 was realized by selling the stock at an average price of $8.06. This leaves the insider owning 378,238 shares of the company worth $3.25 million. Insiders disposed of 136,193 shares of company stock worth roughly $1.17 million over the past 1 year. A total of 3.10% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in SEER stock. A new stake in Seer Inc. shares was purchased by STATE OF WISCONSIN INVESTMENT BOARD during the first quarter worth $807,000. NORGES BANK invested $562,000 in shares of SEER during the first quarter. In the first quarter, CAPITAL IMPACT ADVISORS, LLC acquired a new stake in Seer Inc. valued at approximately $201,000. ALGERT GLOBAL LLC acquired a new stake in SEER for approximately $149,000. PRINCIPAL FINANCIAL GROUP INC purchased a new stake in SEER valued at around $102,000 in the second quarter. In total, there are 164 active investors with 86.20% ownership of the company’s stock.
A candlestick chart of Seer Inc. (NASDAQ: SEER) showed a price of $7.99 on Friday morning. During the past 12 months, Seer Inc. has had a low of $5.96 and a high of $33.23. As of last week, the company has a debt-to-equity ratio of 0.00, a current ratio of 33.10, and a quick ratio of 32.60. The fifty day moving average price for SEER is $7.82 and a two-hundred day moving average price translates $10.21 for the stock.
The latest earnings results from Seer Inc. (NASDAQ: SEER) was released for Jun, 2022. According to the Biotechnology Company, earnings per share came in at -$0.37, beating analysts’ expectations of -$0.39 by 0.02. This compares to -$0.30 EPS in the same period last year. The company reported revenue of $3.96 million for the quarter, compared to $2.15 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 83.53 percent. For the current quarter, analysts expect SEER to generate $3.51M in revenue.
Seer Inc.(SEER) Company Profile
Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome. It develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that allows researchers to conduct proteomic studies in therapeutic and diagnostic research, and clinical trials. The company intends to sell its products for research purposes, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. It has a collaboration agreement with Discovery Life Sciences, LLC. and the Salk Institute for Biological Studies. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California.